Jonathan Tobin, PhD, promoted to Managing Director, Arix Bioscience

LONDON, 15 April 2020: Arix Bioscience plc (LSE: ARIX) (“Arix” or the “Company”), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces changes to the Company’s investment team. These build on the Board of Directors and executive leadership changes announced on 6 April 2020, to right-size the organisation as the Company shifts to value realisation from its current portfolio, to set the stage for future growth.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...